Inspire interim CFO files initial Form 3 holdings
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
Inspire Medical Systems' interim CFO Richard Buchholz filed an initial Form 3 reporting his beneficial ownership in Inspire Medical Systems, Inc. He directly holds 44,567 common shares, including 5,974 restricted stock units, and has employee stock options over 4,376, 5,450, 5,924 and 17,300 shares. He also reports indirect ownership of 1,475 common shares held by his son.
Insider Trade Summary
Holdings reported, no transactions
Holdings
Insider
Buchholz Richard
Role
Interim CFO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| Holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| Holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| Holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
Holdings:
Employee Stock Option (Right to Buy) — 33,050 contracts (Direct);
Common Stock — 44,567 shares (Direct);
Common Stock — 2,950 shares (Indirect, By Son)
Footnotes (4)
- F1. Includes 5,974 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs will vest in accordance with the terms of the underlying awards.
- F2. The option vested and became exercisable as to 25% of the underlying shares on February 9, 2025. The remaining 75% of the underlying shares will vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.
- F3. The option vested and became exercisable as to 25% of the underlying shares on February 10, 2024. The remaining 75% of the underlying shares will vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.
- F4. The option is fully vested and exercisable.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Inspire Medical Systems (INSP) interim CFO report on this Form 3?
The interim CFO, Richard Buchholz, reports his initial beneficial ownership in Inspire Medical Systems common stock, including directly held shares, restricted stock units, stock options, and indirect holdings attributed through his son, as of the Form 3 event date of January 9, 2026.
What indirect Inspire Medical Systems (INSP) holdings are reported on behalf of Richard Buchholz?
The Form 3 reports 1,475 shares of Inspire Medical Systems common stock as indirectly owned by Richard Buchholz through his son. These indirect holdings are shown separately from his direct holdings, indicating beneficial ownership through a related family member.
What stock options in Inspire Medical Systems (INSP) does the interim CFO hold?
Richard Buchholz holds several employee stock options to buy Inspire Medical Systems common stock: options over 4,376, 5,450, 5,924 and 17,300 shares, each with specified exercise prices and expiration dates between February 2032 and February 2034, as shown in the Form 3 table.
How do the restricted stock units (RSUs) for INSP reported by the interim CFO vest?
The filing states that 5,974 restricted stock units each represent a contingent right to receive one share of Inspire Medical Systems common stock. These RSUs will vest according to the terms of the underlying awards, which govern timing and conditions for share delivery.
What are the vesting terms for key Inspire Medical Systems (INSP) stock options held by the interim CFO?
One option vested 25% on February 9, 2025, and another 25% on February 10, 2024. For each, the remaining 75% vests in 36 equal monthly installments, contingent on Richard Buchholz’s continuous employment with Inspire Medical Systems through the respective vesting dates.
AI-generated analysis. How Rhea-AI works. Not financial advice.
